Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer.
Retrospective and non-randomized nature. Additionally, the retrospective analysis did not allow for verification of the duration or regularity of drug use, which made it infeasible to examine dose-response relationships with reliability.
Authors
- İbrahim Vedat Bayoğlu (ORCID: https://orcid.org/0000-0002-0481-1084)
- Selver Işık (ORCID: https://orcid.org/0000-0002-2726-1740)
- Özlem Erçelep (ORCID: https://orcid.org/0000-0001-5892-3519)
- Nargız Majidova (ORCID: https://orcid.org/0000-0002-2575-5819)
- Pınar Erel (ORCID: https://orcid.org/0000-0002-2797-2075)
- Rukiye Arıkan (ORCID: https://orcid.org/0000-0003-2688-1515)
- Ali Kaan Güren (ORCID: https://orcid.org/0000-0002-3562-5006)
- Abdüssamet Çelebi (ORCID: https://orcid.org/0000-0002-6922-1018)
- Nadiye Sever
- Murat Sarı (ORCID: https://orcid.org/0000-0003-0596-1559)
- Alper Yaşar (ORCID: https://orcid.org/0000-0001-8814-8947)
- Yeşim Ağyol (ORCID: https://orcid.org/0000-0002-4409-6003)
- Erkam Kocaaslan (ORCID: https://orcid.org/0000-0002-8994-2904)
- Emil Yunusov
Institutions
- Istanbul Medipol University (TR)
- Marmara University (TR)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-07
- DOI
- https://doi.org/10.5144/0256-4947.2025.18
- Citations
- 3
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 4.56